DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prolastin (Alpha 1-Antitrypsin) - Published Studies

 


Nutrilib.com
A comprihensive source of nutritional information

Prolastin Related Published Studies

Well-designed clinical trials related to Prolastin (Alpha 1-Antitrypsin)

Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma--results from the ALA-ACRC low-dose theophylline trial. [2007.10]

Alpha-1-antitrypsin replacement therapy: current status. [2006.03]

Multi-center study: the biochemical efficacy, safety and tolerability of a new alpha1-proteinase inhibitor, Zemaira. [2006.03]

Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis. [2006.02]

Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency. [2005.05.31]

Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome? [2005]

Prevalence of alpha1-antitrypsin phenotypes in patients with IgA nephropathy. [2004.12]

Protease inhibitors alpha1-antitrypsin and ilomastat are not ototoxic in the chinchilla. [2003.10]

Peripheral deposition of alpha1-protease inhibitor using commercial inhalation devices. [2003.08]

Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin. [2002.07]

Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society. [2001.03]

Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants. [2001]

Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group. [2000.03]

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. [1999.11]

Functional and antigenic concentrations of alpha-1-proteinase inhibitor after administration for the prevention of chronic lung disease of prematurity. [1999.09]

alpha1-Proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity: a randomized, controlled trial. [1998.01]

Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT. [1997.09]

Efficacy of systemically administered acetylsalicylic acid plus scaling on periodontal health and elastase-alpha 1-proteinase inhibitor in gingival crevicular fluid. [1996.03]

Effects of low dose methotrexate therapy on the concentration and the glycosylation of alpha 1-acid glycoprotein in the serum of patients with rheumatoid arthritis: a longitudinal study. [1994.12]

Well-designed clinical trials possibly related to Prolastin (Alpha 1-Antitrypsin)

The benefit of daily photoprotection. [2008.05]

No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. [2006.07]

Rectal bleeding in infancy: clinical, allergological, and microbiological examination. [2006.04]

Effects of ulinastatin on pulmonary artery pressure during abdominal aortic aneurysmectomy. [2006.02]

Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. [2005.02]

Residues 34-39 in the thyrotropin receptor are not the target of autoantibodies from sera of patients with Graves' disease. [2004.08]

Tissue trauma after vaginal hysterectomy and colporrhaphy versus abdominal hysterectomy: a randomised controlled study. [2004.08]

Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. [2004.03]

Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis. [2003.11]

The value of routine antibiotic prophylaxis in mandibular third molar surgery: acute-phase protein levels as indicators of infection. [2001.06]

Tension-free hernia repair is associated with an increase in inflammatory response markers against the mesh. [2000.09]

A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. [2000.07]

Treatment of iron deficiency anemia and associated protein-losing enteropathy in children. [2000.01]

Activation of the contact system of coagulation does not contribute to the hemostatic imbalance in hypertriglyceridemia. [1999.10]

Reducing neutrophil elastase-induced lung injury. [1999.03]

Inhaled budesonide in ventilator-dependent preterm infants: a randomized, double-blind pilot study. [1999]

Activation of the protein C system during cardiopulmonary bypass with and without aprotinin. [1998.12]

Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors. [1998.08]

Steroids in the hemolytic uremic syndrome. [1998.02]

Probiotics: a novel approach in the management of food allergy. [1997.02]

Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics. [1995.05]

Local serum application: restoration of sufficient host defense in human peritonitis. [1994.01]

Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. [1994.01]

Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. [1993.06]

The effect of bed rest and intra-articular steroids on the acute phase response in rheumatoid arthritis. [1993.01]

The effect of epidural blockade on postoperative hypercoagulability following abdominal aortic bypass surgery. [1992.11]

The influence of tourniquet ischaemia on post-operative degranulation of polymorphonuclear granulocytes. [1992.05]

Attenuation of intra-operative surgical stress response has no influence on post-operative degranulation of polymorphonuclear granulocytes. [1991.09]

Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. [1991.05]

Comparison of the clinical performance, contraceptive efficacy and acceptability of levonorgestrel-releasing IUD and Norplant-2 implants in China. [1990.05]

Blood coagulation in postmenopausal women given estrogen treatment: comparison of transdermal and oral administration. [1988.02]

Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. [1987.10]

Other research related to Prolastin (Alpha 1-Antitrypsin)

Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro. [2008.07]

[Effect of a high glucose load on serum concentrations of C-reactive protein and alpha1-antitrypsin in obese women] [2008.07]

Endothelial alpha-1-antitrypsin attenuates cigarette smoke induced apoptosis in vitro. [2008.06]

Longitudinal decline of diffusing capacity of the lung for carbon monoxide in community subjects with the PiMZ alpha1-antitrypsin phenotype. [2008.05]

Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy. [2008.05]

Alpha-1 antitrypsin: now available, but do we need it? [2008.04.05]

Augmentation therapy in alpha-1 antitrypsin deficiency. [2008.04]

Inhaled Corticosteroids as Additional Treatment in Alpha-1-Antitrypsin-Deficiency-Related COPD. [2008.03.04]

Alpha-1 antitrypsin treatment of spontaneously diabetic nonobese diabetic mice receiving islet allografts. [2008.03]

Prolonged islet allograft survival by alpha-1 antitrypsin: the role of humoral immunity. [2008.03]

Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances. [2008.02.13]

Longitudinal Decline of Diffusing Capacity of the Lung for Carbon Monoxide (DL,CO) in Community Subjects with the PiMZ {alpha}1-Antitrypsin Phenotype. [2008.02.08]

Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment. [2008.01]

IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. [2008.01]

Influenza vaccination in subjects with alpha1-antitrypsin deficiency. [2008.01]

Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD. [2008]

The prevalence of alpha(1)-antitrypsin deficiency in a representative population sample from Poland. [2007.12]

Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency. [2007.10]

The promise of gene therapy for the treatment of alpha-1 antitrypsin deficiency. [2007.09]

Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency. [2007.09]

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. [2007.09]

The prevalence of alpha(1)-antitrypsin deficiency in a representative population sample from Poland. [2007.08.09]

Alpha1-antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophages. [2007.08]

Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. [2007.08]

Fecal alpha1--antitrypsin in healthy and intestinal-disorder Thai children. [2007.07]

Alpha1-antitrypsin heterozygosity plays a positive role in attainment of longevity. [2007.04]

Rapid and Inexpensive Detection of {alpha}1-Antitrypsin Deficiency-Related Alleles S and Z by a Real-Time Polymerase Chain Reaction Suitable for a Large-Scale Population-Based Screening. [2007.02]

{alpha}1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. [2007.02]

Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency. [2007.02]

Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency. [2007.01]

Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics. [2006.12]

Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults. [2006.12]

Identification of a 4-mer Peptide Inhibitor that Effectively Blocks the Polymerization of Pathogenic Z {alpha}1-Antitrypsin. [2006.11]

Yield improvement for manufacture of alpha-proteinase inhibitor. [2006.11]

Alpha-1-antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. [2006.10.18]

Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency. [2006.10]

[Pharmacokinetics of alpha1-antitrypsin replacement therapy in severe congenital emphysema] [2006.10]

Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma. [2006.09]

Prolastin aerosol therapy and sputum taurine in cystic fibrosis. [2006.08]

Ventilation inhomogeneity in alpha1-antitrypsin-deficient emphysema. [2006.08]

Alpha1-antitrypsin single dose adjuvant therapy for acute otitis media. [2006.07]

A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema. [2006.06.01]

Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice. [2006.06]

Inhaled recombinant alpha 1-antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. [2006.06]

Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use. [2006.06]

High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses. [2006.01]

Quantitative assessment of emphysema distribution in smokers and patients with alpha1-antitrypsin deficiency. [2006.01]

Results of a survey of patients with alpha-1 antitrypsin deficiency. [2006]

Tempting liver fibrosis? Long-term psoriatic methotrexate therapy and heterozygous alpha1-antitrypsin deficiency. [2006]

[National cohort of patients with emphysema and alpha-1 antitrypsin deficiency] [2005.12]

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008